Lucinda Camras, PhD

Chief Scientific Officer

Lucinda Camras, PhD is an renown expert in aqueous humor dynamics, ophthalmic surgery, and ocular devices.  She was one of the youngest principal investigators to receive funding in 2013 from the National Science Foundation (NSF) and continues to receive funding from government agencies ($3M+ total).  She has been published in the top ophthalmic journals, has 10 US patents issued or pending, and has received numerous awards.  Prior to Camras Vision, Lucinda has served as a scientific director for an ophthalmic startup working on a novel presbyopia procedure and served consultant to another ophthalmic startup working in glaucoma.  She has worked with many key opinion leaders during her training and continued these collaborations post graduate school.  Lucinda holds a B.S. degree in Biomedical Engineering from Northwestern University and Ph.D. degree in Biomedical Engineering from Duke University. She was honored by being awarded the Notable Alum of the 2010s for the Duke Graduate School 90th Anniversary.

Sanjay Asrani, MD

Chief Medical Officer

Dr. Asrani is a board certified ophthalmologist with more than 15 years of experience in glaucoma and clinical trials. He currently practices glaucoma surgery at the Duke Eye Center where he has implanted over 500 shunts in patients. Dr. Asrani completed his fellowship at Duke where he also serves as a Professor of Ophthalmology.

Roberto Alfaro, MBA

Chief Operating Officer

Roberto is an executive with over 14 years of experience in the finance and health care industries. He has worked with several life science & commercial startups performing business development, finance, and operational activities. Earlier in his career he worked as a Manager for Deloitte doing risk and operational consulting.

Ray Krauss, MS,MBA

Chief Executive Officer

Ray Krauss has 30+ years executive experience in the medical device industry. His experience includes both PMA and 510(k) devices as well as working in private & public companies. He led the operations effort of the first company, Summit Technology, to bring PRK/LASIK to the market

Rob Rothman, MD

Board Member

Dr. Rothman is a partner at Glaucoma Consultants of Long Island, where he maintains an active role in research, education, and patient care activities. He is also a partner in Prescient-Biometric Investment Group, where they focus on ophthalmic companies.

Tim Willis

Board Member

Mr. Willis is an entrepreneur with 30 years of healthcare industry experience. Directly responsible for development of 55+ products that currently represents over one and half billion dollars in annual revenue. Founded or helped start 8 companies and raised or helped raise over $200M